Home Tourmaline Bio

Tourmaline Bio

acquired
IPO Delisting
Pharmaceutical R&D Developer

Basic Information

Tourmaline Bio is a late-stage clinical biotechnology company with a mission to develop transformative drugs that significantly improve the lives of patients with life-altering immune diseases. In doing so, we aim to develop drugs with the potential to establish new standards of care in areas of high unmet medical need.
Tourmaline Bio, Inc.
NewYork,NewYork,United States of America
15~50 people
January 01, 2021
info@tourmalinebio.com